Stockreport

TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF BORDEAUX, France--(BUSINESS WIRE)--TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell techn [Read more]